Your browser doesn't support javascript.
loading
Body mass index is inversely associated with capillary ketones at the time of colonoscopy: Implications for SGLT2i use.
Hamblin, Peter S; Wong, Rosemary; Ekinci, Elif I; Sztal-Mazer, Shoshana; Balachandran, Shananthan; Frydman, Aviva; Hanrahan, Timothy P; Hu, Raymond; Ket, Shara N; Moss, Alan; Ng, Mark; Ragunathan, Sashikala; Bach, Leon A.
Affiliation
  • Hamblin PS; Department of Endocrinology and Diabetes, Western Health, Melbourne, Victoria, Australia.
  • Wong R; Department of Medicine, Western Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Ekinci EI; Department of Endocrinology and Diabetes, Eastern Health, Melbourne, Victoria, Australia.
  • Sztal-Mazer S; Department of Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
  • Balachandran S; Department of Endocrinology, Austin Health, Melbourne, Victoria, Australia.
  • Frydman A; Department of Medicine, Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia.
  • Hanrahan TP; Department of Endocrinology and Diabetes, Alfred Health, Melbourne, Victoria, Australia.
  • Hu R; School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
  • Ket SN; Department of Medicine, Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
  • Moss A; Department of Endocrinology and Diabetes, Eastern Health, Melbourne, Victoria, Australia.
  • Ng M; Department of Endocrinology and Diabetes, Western Health, Melbourne, Victoria, Australia.
  • Ragunathan S; Department of Gastroenterology and Liver Transplant Unit, Austin Health, Melbourne, Victoria, Australia.
  • Bach LA; Department of Medicine, Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia.
Clin Endocrinol (Oxf) ; 96(4): 549-557, 2022 04.
Article de En | MEDLINE | ID: mdl-34697809
ABSTRACT

OBJECTIVE:

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have been associated with diabetic ketoacidosis at the time of colonoscopy. This study aimed to identify factors associated with ketone concentrations in SGLT2i-treated type 2 diabetes compared with non-SGLT2i-treated diabetes, and those with impaired fasting glycaemia (IFG) and normoglycaemia.

DESIGN:

Cross-sectional, multicentre, observational study June-December 2020 in four Australian tertiary hospitals.

PARTICIPANTS:

Capillary glucose and ketones were measured in people undergoing colonoscopy 37 SGLT2i-treated and 105 non-SGLT2i-treated type 2 diabetes, 65 IFG and 151 normoglycaemia. MEASUREMENTS Body mass index (BMI), age, glucose, fasting duration and where relevant, HbA1c and time since last SGLT2i dose.

RESULTS:

In SGLT2i-treated diabetes, BMI (ρ = -0.43 [95% confidence interval -0.67, -0.11]) and duration since last SGLT2i dose (ρ = -0.33 [-0.60, 0.00]) correlated negatively with increasing ketones, but there was no correlation with fasting duration. In non-SGLT2i-treated diabetes, BMI correlated negatively (ρ = -0.24 [-0.42, -0.05]) and fasting duration positively (ρ = 0.26 [0.07, 0.43]) with ketones. In IFG participants, only fasting duration correlated with ketones (ρ = 0.28 [0.03, 0.49]). In normoglycaemic participants, there were negative correlations with BMI (ρ = -0.20 [-0.35, -0.04]) and fasting glucose (ρ = -0.31 [-0.45, -0.15]) and positive correlations with fasting duration (ρ = 0.20 [0.04, 0.35]) and age (ρ = 0.19 [0.03, 0.34]). Multiple regression analysis of the entire cohort showed BMI, age and fasting glucose remained independently associated with ketones, but in SGLT2i-treated participants only BMI remained independently associated.

CONCLUSIONS:

In SGLT2i-treated diabetes, lower BMI was a novel risk factor for higher ketones precolonoscopy. Pending larger confirmatory studies, extra vigilance for ketoacidosis is warranted in these people.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: État prédiabétique / Diabète de type 2 / Inhibiteurs du cotransporteur sodium-glucose de type 2 Type d'étude: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Pays/Région comme sujet: Oceania Langue: En Journal: Clin Endocrinol (Oxf) Année: 2022 Type de document: Article Pays d'affiliation: Australie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: État prédiabétique / Diabète de type 2 / Inhibiteurs du cotransporteur sodium-glucose de type 2 Type d'étude: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Pays/Région comme sujet: Oceania Langue: En Journal: Clin Endocrinol (Oxf) Année: 2022 Type de document: Article Pays d'affiliation: Australie
...